We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.375 | 3.98% | 9.80 | 9.80 | 9.90 | 10.00 | 9.20 | 9.40 | 2,889,460 | 15:38:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.71M | -11.11M | -0.0441 | -2.22 | 24.72M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/8/2020 08:57 | Seriously under valued stock, we could potentially 10 bag with the right news ... which is on its way ..... | rakepat37 | |
21/8/2020 07:46 | He was speaking generally on USA pharma valuations. | amaretto1 | |
20/8/2020 22:00 | Interesting that Clive has referred to US comparators. There is only one US comparator in my book. Schrodinger a computational biology Company where Bill Gates and D.E.Shaw own 50%. SDGR Mkt Cap $5000m C4XD Mkt Cap $30m I think C4XD can easily support a Mkt Cap of $300m i.e. 10x the current price Noteable that tech specialists Polar Capital invested just months after Schrodinger listing and successful listing at that as it went from $17 IPO price in February to $60-70 in April/May | the stigologist | |
20/8/2020 20:47 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | astorcourt | |
20/8/2020 20:46 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | astorcourt | |
20/8/2020 20:46 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | astorcourt | |
20/8/2020 20:46 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | astorcourt | |
20/8/2020 20:46 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | astorcourt | |
20/8/2020 20:16 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | alloa2003 | |
20/8/2020 20:16 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | alloa2003 | |
20/8/2020 20:16 | Cheers, good to hear. To be fair he hasn't diverted from this story since day one. If he hadnt been shafted at the last minute with the first fund raising then we wouldnt be anywhere near this price. If the fund raising had been circa 40p (as was rumoured) then sentiment towards the stock would be very different. | alloa2003 | |
20/8/2020 18:29 | He didn't divulge anything the world is not aware of .....He sounded very confident on achieving the given goal ! Referred to US Valuations in this sector ...The global future of early stage pharma discovery's The big boys are now embracing this !! | amaretto1 | |
20/8/2020 18:12 | Hi Amaretto1, Is there any info you can divulge about your chat. I appreciate this may have been a private chat not to be repeated. | alloa2003 | |
20/8/2020 16:56 | Justin is talking sense ...My target is 100 +++ pence Since talking to Clive recently. | amaretto1 | |
20/8/2020 16:30 | probably sold already and made a quick 10-15% | pugg1ey | |
20/8/2020 16:24 | I agree DaveMac3, good on the way up but when he pulls the trigger to sell, all the sheep will follow. However, it has got people talking about the potential for C4XD. | alloa2003 | |
20/8/2020 16:23 | I'm sure C4XD Clive and Bhajna can/will cope | the stigologist | |
20/8/2020 16:22 | Not sure it's a good thing having rampmeister general Justin Waites on board The Stigologist20 Aug '20 - 14:53 - 1935 of 1938 0 1 0 Sharepickers Justin Waite out with a decent and v bullish write up on C4XD Chart shows potential for melt up from 20p to 40p CEO bought stock at 60-100p Chart shows potential for at least 100p but Justin talking potential 20x ! | davemac3 | |
20/8/2020 15:17 | Bit of a ding dong on Twitter about C4XD lol | alloa2003 | |
20/8/2020 15:07 | The key to this is simple. The next decent size payment/deal will allow the company to be self-funding (if it isnt already) from here on in with no concerns about fund raising and dilution. This in turn will allow them to investigate other molecules. Then this is where the fun starts.... It is the cumulative impact of long term income which will make the difference - some of which will be stage payments in the early days then royalties on successful treatment sales further down the line. So if they have 2, 3, 4, etc successful treatments this can/would create huge cashflow. Lets assume royalties per treatment of $10m a year. Year 1 - 1 treatment, 1 x $10m = $10m Year 2 - 2 treatments, 2 x $10m = $20m Year 3 - 3 treatments, 3 x $10m = $30m If the royalties are higher/they can partner more molecule treatments then the cumulative income will be even greater. If all goes to plan it would be a cash cow. | alloa2003 | |
20/8/2020 14:53 | Sharepickers Justin Waite out with a decent and v bullish write up on C4XD Chart shows potential for melt up from 20p to 40p CEO bought stock at 60-100p Chart shows potential for at least 100p but Justin talking potential 20x ! | the stigologist | |
20/8/2020 14:51 | Interesting to see buyers coming back in on any weakness. | alloa2003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions